HIT remains a commonly encountered iatrogenic complication of heparin therapy in hospitalized patients. In the nearly 6 decades since the initial descriptions of the disease, there have been major advances in understanding the pathogenesis of HIT, its varied clinical complications and treatment. Emerging anticoagulant therapies hold promise not only for the treatment of HIT but also in reducing its incidence.